Revenue: The sum of all revenue fields included for a company's operating activities.
TNF Pharmaceuticals, Inc. (QCLS) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-27.16M |
|
-- |
|
-- |
|
$10.17M |
|
$-10.17M |
|
$-13.19M |
|
$-23.36M |
|
$-23.36M |
|
$-23.36M |
|
$-23.36M |
|
$-23.36M |
|
$-23.36M |
|
$-10.17M |
|
$-10.17M |
|
0.02M |
|
0.02M |
|
$-1115.00 |
|
$-1115.00 |
|
| Balance Sheet Financials | |
$9.41M |
|
-- |
|
$12.01M |
|
$21.42M |
|
$6.70M |
|
-- |
|
$4.93M |
|
$11.63M |
|
$9.65M |
|
$-0.71M |
|
$9.79M |
|
0.03M |
|
| Cash Flow Statement Financials | |
$-8.98M |
|
$-6.10M |
|
$12.57M |
|
$2.68M |
|
$0.17M |
|
$-2.51M |
|
$1.66M |
|
-- |
|
$-1.36M |
|
| Fundamental Metrics & Ratios | |
1.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-242.19% |
|
3295.62% |
|
-109.05% |
|
-238.61% |
|
$291.01 |
|
$-368.34 |
|
$-368.34 |
|